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Abstract: Infections with antimicrobial-resistant (AMR) bacteria are globally on the rise. In the future,
multi-resistant infections will become one of the major problems in global health care. In order to
enable reserve antibiotics to retain their effect as long as possible, broad-spectrum antibiotics must
be used sparingly. This can be achieved by a rapid microfluidic phenotypic antibiotic susceptibility
test, which provides the information needed for a targeted antibiotic therapy in less time than
conventional tests. Such microfluidic tests must cope with a low bacteria concentration. On-chip
filtering of the samples to accumulate bacteria can shorten the test time. By means of fluorescence
microscopy, we examined a novel nanogap filtration principle to hold back Escherichia coli and to
perform cultivation experiments with and without antibiotics present. Microfluidic chips based on
the nanogap flow principle showed to be useful for the concentration and cultivation of E. coli. With a
concentration of 106 cells/mL, a specific growth rate of 0.013 min−1 and a doubling time of 53 min
were achieved. In the presence of an antibiotic, no growth was observed. The results prove that this
principle can, in future, be used in fast and marker-free antimicrobial susceptibility testing (AST).
Keywords: antimicrobial resistance; microfluidics; cell capture; lab-on-a-chip; microcultivation;
miniaturization
1. Introduction
Antimicrobial-resistant (AMR) bacteria are currently one of the major threats in global health care.
Due to the rampant use of antibiotics in animal fattening and human medicine, antibiotic resistance
continues to spread across the globe [1]. The deaths caused by antibiotic-resistant infections were
estimated to be as high as 700,000 in 2014. If no actions are taken, this number is expected to rise to
10 million people by 2050, overtaking the number of cancer deaths worldwide [2]. One key aspect to
preventing these deaths is to ensure that reserve antibiotics retain their efficacy as long as possible.
Rapid antibiotic resistance diagnostic procedures can make an important contribution to the correct
and economical use of antibiotics. In addition, rapid resistance diagnostic procedures can accelerate
the therapy of patients and reduce the risk of dying by sepsis, which is the main cause of death in
intensive care units in hospitals [1]. If these devices are widely available and used, the unnecessary
overprescription of broadband antibiotics could be avoided [3].
Currently, the available methods for antimicrobial susceptibility testing (AST) can be divided into
genetic and phenotypic methods. Genetic ASTs are based on the analysis of the genome to find genes
associated with antibiotic resistance found in a patient’s blood culture. While this can be achieved
in around 1 to 2 h, it has the disadvantage that only known genetic markers can be detected, which
are not always linked to phenotypic resistance behavior [4]. In addition, if no unknown mechanisms
Micromachines 2019, 10, 691; doi:10.3390/mi10100691 www.mdpi.com/journal/micromachines
Micromachines 2019, 10, 691 2 of 12
of resistance can be detected, this can lead to false negative results and thus the wrong medication
given to the patient. When working with uncultured blood, the slightest contamination of the sample
can lead to false positives when unrelated DNA is detected [5]. Due to these disadvantages of genetic
assays, phenotypic assays are better suited for routine examinations. Phenotypic ASTs are based on
the analysis of the growth behavior of bacteria in the presence of certain antibiotics in the culture
medium. Conventionally, this is done in shaking cultures by measuring optical turbidity or on agar
plates where the areas that are not overgrown by bacteria around antibiotic releasing surfaces are
measured. This kind of resistance determination has the advantage that a resistance can be determined
independently of the existing resistance mechanisms. These systems have the drawback that they need
an overnight cultivation (24–72 h) before results can be evaluated [6]. To shorten this test duration,
many new microfluidic-based phenotypic ASTs have been developed [7]. One approach is to combine
a liquid bacterial culture with liquid agarose, which solidifies during cooling and holds the bacteria
in a nutrient matrix. Antibiotics are then directed to the bacteria by diffusion and their minimum
inhibitory concentration (MIC) is determined with single bacteria time-lapse imaging after 3 to 4 h [8].
This approach to diagnose antibiotic susceptibility is also used in other systems which obtained similar
detection times (2.5 to 4 h) [9,10]. The detection principle however has the disadvantage of not providing
concentration of bacteria. This leads to the fact that only bacterial samples with initial concentrations
over 108 cells/mL can be examined. Another attempt to build a fast AST is based on the mother machine
design [11]. It has been adapted to allow better filling with bacterial samples and consists of 2000
cell traps. The testing principle relies on optical time-lapse observation with image analysis to detect
bacterial growth inside these cell traps [12]. A disadvantage of this system is clogging, created by using
a dead-end filter principle, which leads to challenges when dealing with polymicrobial infections [13].
By using a single droplet system, the MIC of Escherichia coli was measured by the metabolism of
resazurin. However, only a bacterial concentration of 105 CFU/mL could be measured [14]. In addition,
gradient-based measurements were conducted [15]. Other groups use automated microdroplet systems
to test combinations of antibiotics on bacteria [16,17]. While this method is very well suited for drug
research [18], it is not so well suited for rapid AST, as in reality these high concentrations of bacteria
are not always present in patient samples, which makes sample concentration necessary [14]. This
restriction applies to several other systems where an external upstream filtration is needed [1]. Another
method to investigate E. coli proliferation is by capturing them on membrane filters and real-time
observation of expression dynamics via fluorescence microscopic detection of markers and therefore
is not marker-free [19]. In another approach, the filtration is realized in 2.5 nL wells with stacked
beads to lower the required minimum initial concentration in the sample to 105 cells/mL for measuring
the phenotypic response to antibiotics in 100 min [20]. The same applies to another system which
only detects the fluorescent intensity [21]. In a further approach, bacteria are hydrodynamically
captured in traps and the growth rate is examined individually in the presence of antibiotics. This
system was tested with a concentration of 107 CFU/mL [22]. By measuring electric fluctuations in a
microfluidic channel, the antibiotic resistance of E. coli in the concentration range of 105–107 cells/mL
could be measured [23]. Furthermore, centrifugal microfluidics enables the MIC determination of
106 cells/mL E. coli suspensions [24]. In addition, the difference in MIC by the treatment of bacterial
biofilm in comparison to fluid cultures has been investigated in microfluidics, concluding that higher
concentrations of antibiotics are needed to treat bacteria grown in biofilms and not under planktonic
conditions [25]. Many of these microfluidic systems consist of polydimethylsiloxane (PDMS), which
are easy to fabricate and air permeable. However, the use of PDMSs can lead to problems when the
low MIC of antibiotics has to be tested because of the absorption of small molecules and drugs during
the testing [26–28].
In order to examine uncultured and therefore low concentrated samples in microfluidics,
one challenge to be addressed is the on-chip filtration of the bacteria in small volumes to raise
the concentration. This has to be done without clogging the system. This paper presents microfluidic
capture to immobilize and detect the growth of E. coli which is suitable for chip-based ASTs. The basic
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principle behind this approach has already been used for the immobilization of human leukemic cells
which were retained at a 5 µm gap and optically examined from above [29]. For the much smaller
bacteria however, the design and manufacturing of the gap structure required a completely novel
bypass cross-flow (BCF) approach.
2. Materials and Methods
2.1. Microfluidic Chip Design
A schematic of the 10 × 10 mm BCF capture chip (Figure 1) shows the chip with inlet and outlet
ports as well as the middle part of the chip, where the immobilization of bacteria is achieved at a
nanogap between two 296 µm long parallel channels. They are connected by a shallow (300 nm) gap
which is also 296 µm long and allows bacteria to be immobilized hydrodynamically by using different
pressure levels on each side of the gap. The two channels are 3 µm apart and have a cross-section
of 3 × 4 µm (see Figure 1a). Each end of these parallel channels is connected to a 50 × 50 µm bypass
channel that is connected to one of the eight fluidic inlet and outlet ports on the bottom of the chip.
This allows a quick loading of the gap area with bacteria and a fast exchange of the growth medium.
By varying the pressure in the bypass channels, the flow through the capture channels and the gap
region can be adjusted. This enables the capture as well as the release of bacteria.
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A top view of the etched silicon structures is shown in Figure 2b. A glass wafer was locally etched 
with a depth of 400 nm with hydrofluoric acid to build the nanogap structure by anodic bonding with 
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connections were dry etched from the backside into the silicon. Then the wafers were diced to 10 × 
10 mm chips, as shown in Figure 2a. 
Figure 1. (a) Cross-section of the capturing area with a bacterium moving towards the nanogap, driven
by a pressure difference between the channels. (b) Schematic top view of the 10 × 10 mm silicon-glass
chip with eight microfluidic inlets and outlets at the bottom of the chip. (c) Schematic three-dimensional
view of t e capture features of the chip. (d) Detailed top view of the capture area in the red box with
capture and reference channels, bypass chann ls, and nanogap area.
2.2. Microfabrication
The chip used in this study was made of silicon and glass. The parallel fluidic channels were
etched 4 µm deep into a silicon wafer using reactive ion etching in an inductive coupled plasma
etcher (SPTS, Newport, UK) with an adapted mixed gas process (SF6/C4F8/Ar = 20/20/5) to get vertical
sidewalls without any scallops [30]. The bypass channels were etched with a gas-switching process.
A top view of the etched silicon structures is shown in Figure 2b. A glass wafer was locally etched
with a depth of 400 nm with hydrofluoric acid to build the nanogap structure by anodic bonding
with the silicon wafer. A cross-section of the bonded wafer is shown in Figure 2c. After bonding,
fluidic conn ctions were dry etched from the backside into the silicon. Then the wafers were diced to
10 × 10 mm chips, as shown in Figure 2a.
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Figure 2. (a) Silicon-glass chips with a lateral dimension of 10 × 10 mm after wafer dicing. (b) Top
view of the nanogap area and the bypass channels. (c) SEM image of a cross-section of the nanogap
with reference and capture channels.
2.3. Experimental Setup
The flow through the chip was achieved by eight pneumatic controllers (MFCS-EZ, Fluigent,
Le Kremlin-Bicêtre, France), which were connected to eight 2 mL sample vials (Biozym Scientific
GmbH, Hessisch Oldendorf, Germany), schematically shown in Figure 3a. The same tubing was
used for connecti g reservoirs with the icrochip. A polytetrafl oroethylene (PTFE) filter membrane
(Whatman, Maidstone, UK) between the tube outlets and the microchip ports was used to prevent
clogging of the chip by particles bigger than 5 µm. Reservoirs and chip were laced on a fluorescence
microscope (Axio Observer 3, Zeiss GmbH, Jena, Germany), surrounded by an incubator to maintai
a cultivati n temperature of 37 ◦C. Connecting compone ts were designed and constructed out of
PTFE. To avoid leakage, O-rings were placed between the fluidic chip and the PTFE holder, as shown
in Figure 3b.
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2.4. Bacterial Strain and Growth Medium
Cell capture and growth experiments were conducted using E. coli DH5-aplha cells containing
the plasmid PS858 [31]. T is las id encodes the g nes bla (beta-lactam-resistance), aacC1
(gentamicin-resistance), and GFP (green fluorescent protein). Bacterial dilutions in the range of
105 to 107 cells/mL were prepared in Terrific Br th (TB) growth medium (Lionex GmbH, Brau schweig,
Germany) containing 100 µg/mL carbenicillin (beta-lactam-antibiotic) and 10 µg/mL gentamicin-sulfat ,
which was also used as culture medium. Both antibiotics were added for selection of the used strain,
carrying corresponding resistance genes. For growth inhibition experiments, a 200 µg/mL amount of
kanamycin was added to the medium, whi h is 100-fold above the minimum inhibitio concentration
(MIC) of kanamycin (2 µg/mL) [32]. Pri r to experiments, the bacteria suspension and TB edium were
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filtered with a 5 µm syringe filter (Whatman, Maidstone, UK). Due to the storage at 4 ◦C, the bacteria
suspension and medium were additionally pre-incubated 1 h at 37 ◦C before their use in the growth
experiments. No further treatment was applied to the bacteria.
2.5. Calculation of Growth Rates
Specific growth rates µ and associated standard deviation were calculated using linear fits to
logarithmic cell length over time (t) plots. Additionally, doubling times td with corresponding standard
deviation (Gaussian error propagation) were determined as follows:
µ =
∆ ln(Length)
∆t
(1)
td =
ln(2)
µ
(2)
3. Results and Discussion
3.1. Fluidic Simulations of Shear Forces
For a quick loading procedure, a high flow velocity through the channels is desired. Researchers
must ensure that the shear stress acting on the bacteria surface during capturing is below 1250 Pa,
otherwise the bacteria is damaged and their proliferation is stopped [33]. Therefore, Computational
fluid dynamics (CFD) simulations were carried out using ANSYS Fluent (Version 17.0, ANYSY Inc.,
Canonsburg, PA, USA).
An E. coli bacterium model (0.7 µm diameter and 3.3 µm length) was placed at the nanogap
area, as shown in Figure 4c, and the flow was adjusted so that the resulting force on the bacteria was
directed to the gap. Two local maxima of the shear stress were found on the surface of the bacteria at
the nanogap, as shown in Figure 4c,d. For the maximum desired pressure difference of 2 bar for the
channel inlet to outlet, the shear stress stayed below 1250 Pa at a maximum average shear stress over
the bacterial surface of 485 Pa. A flow rate of 0.2618 µL/min was obtained. With a concentration of 104
E. coli cells/mL, it would theoretically take 10 min to fill the system with 100 bacteria if every E. coli was
captured at the gap area.Micromachines 2019, 10, x 6 of 12 
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To obtain the distribution of the velocity of the flow through the nanogap along the channel,
another flow simulation was carried out. The pressure-driven flow through the gap reached local
maxima at the channel ends (z = 0 and z = L), where the pressure difference between the channels
was the highest, as shown in Figure 4b when the channel is empty. This flow profile prefers capturing
the bacteria at the end (z = L) of the channel and thereby continuously blocks the gap, leading to
continuously reducing the active gap length from the end to the beginning (z = 0). Therefore, the flow
profile continuously changes as the gap is increasingly blocked with bacteria from the end to the front,
as shown in Figure 4b. To prevent clogging, the channels were designed in dimensions to enable
larger particles to pass through the channels even when bacteria were captured, as shown with the
streamlines in Figure 4d.
3.2. Cell Capture Experiments
Before growth experiments could be executed, the right pressure settings of the connected pressure
controllers had to be evaluated. The conducted experiments consisted of capture and growth phases.
For th capture hase, the pressure at the press re contr llers was regulated so that the bacteria sample
flowed through the bypass channel 1 from Inlet 1 to Outlet 1. This resulted in a higher pressure at the
entrance of the detecti n ch nel in the system than in its outlet. The bacteria fl ed int the detection
channel w re captured at the nanogap b a pressure differenc towards the ref r nce cha nel,
schematically shown in Fi ure 5. Capturing a sufficient number of cells at the nanogap took 3–4 min
during typical growth experiments, independent of concentrations varying between 106 cells/mL and
107 cells/mL. The experimentally obtained pressure settings for the capture are shown in Table 1.
Real-time microscopy allowed ideal timing to switch the pressure settings to growth mode.
Including the subsequent adjustment of the imaging setup, the preparation time between pre-incubation
and the beginning of detection took 15 min on average. The pressure difference between the detection
bypass channels was inverted, causing a flow direction from growth medium to bacteria bypass
through the detection microchannel. In some cases, pressures were adjusted in more than one step
to avoid losing too many cells by flushing. For the duration of 4 h, growth mode was kept constant
and the microchip was imaged every 30 s to monitor whether the cells were sufficiently retained and
were growing at the nanogap. The pressure values determined to be suitable for the capture and a 4 h
retention of the bacteria are summarized in Table 1.
The evaluation of the fluorescence pictures was done with ImageJ (Version 1.8.0, NIH, Bethesda,
MD, USA). (A scale was determined with known dimensions of the microchip. Length measurements
of cell agglomerates were performed after adjusting the fluorescence contrast.) The results are shown
in Figure 6. The different cell agglomerates were measured. The density of trapped cells turned out
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to be a limiting factor in the manual graphic analysis. High cell densities in the channel caused cell
overlapping, further enhanced by cell growth. This also resulted in less stable immobilization and
therefore loss of cells during growth experiments. Thus, the number of captured cells was reduced to
avoid overlapping of the bacteria.
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Table 1. Applied pressure settings to inlets (pIn1–pIn4) and outlets (pOut1–pOut4) of the microchip for
growth experiments in capture and growth modes.
Mode Pressure Applied (mbar) at the Inlets and Outlets
pIn1 pOut1 pIn2 pOut2 pIn3 pOut3 pIn4 pOut4
Capture 200 195 195 170 40 40 50 50
Growth 190 180 200 185 40 40 40 40
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(a–c) Three exemplary growth experiments designated A, B, and C. Measured cells are numbered
within each experiment. (d) Negative control with addition of antibiotics (200 µg/mL kanamycin).
Marked are measure cells.
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3.3. Growth Experiments
After pre-incubation, the bacterial dilution containing 106 cells/mL and culture medium were
connected to the microfluidic setup. All growth experiments were carried out at 37 ◦C with TB growth
medium. After initially applying high pressure of 400 mbar for 2 min to fill the tubing and channels,
the system was set to capture mode until the bacteria in the detection channel still had sufficient
space between each other. After filling the channel with bacteria, the pressure setup was switched
to growth mode and no new bacteria were loaded into the channel. An overall lower pressure at
both bacteria bypass ports generated a flow direction from medium to bacteria bypass through the
detection microchannel. This ensured a fresh medium supply to the growing cells. Additionally,
the application of only low pressures to the reference ports led to a pressure difference (∆p = 150 mbar)
between detection and reference microchannel, resulting in suction through the nanogap and thereby
immobilization of cells. Imaging settings (exposure time, gain, and LED intensity) were set individually
to allow optimal fluorescence detection. Every 30 s, a fluorescent image was taken with a custom-made
time-lapse setup.
Due to the marginal flow rate of fresh medium, cells were not separated after division. This
allowed the observation of single cells developing into long cell chains. The increase of total chain
length was analyzed over time. Within single experiments, a high diversity in chain-growth behavior
could be observed. A typical heterogeneity was observed in all conducted experiments. The already
small number of trapped cells inside the microchip was considerably reduced by non-proliferating
and dying cells. With cell death, fluorescence faded during experiments. Moreover, part of the living
cells did not proliferate until the last hour of the experiment. Only a few cells proliferated and led
to growing chains directly from the beginning. This can be explained by phenotypic heterogeneity,
enhanced by stressful conditions and the statistical effect of extremely small populations [34].
Nevertheless, it was possible to analyze cell chain growth, with reproducible results within
and between experiments. Monitoring the length of selected chains over time indicated a phase of
exponential growth starting around 15 min after the beginning of the experiment and stagnation after
about 2 h, typically terminating in length reduction and fading fluorescence.
We further present five exemplary cells, which were investigated thoroughly while developing
into a (growing) chain. Plotting chain lengths over time shows significant growth starting 15 min after
loading for all of them. However, the growth of chain length diverges immensely after 90 min. Thus,
only the period between 15 min and 90 min was taken into account for further analysis.
The specific growth rate was calculated by logarithm of length over time plots. Here, within
the window of 15 min to 90 min, the graphs show a linear trend (Figure 7b). Linear fits lead to
specific growth rates between 0.011 min−1 and 0.016 min−1 with an average specific growth rate of
0.013 min−1. Additionally, doubling times were calculated (= ln(2)/specific growth rate), resulting
in a mean value of 53 min. The results of the individual cells and mean values are summarized in
Table 2. Standard deviations were determined by linear fits (specific growth rate) and Gaussian error
propagation (doubling time).
Table 2. Specific growth rate of each immobilized and observed E. coli cell at the nanogap at 37 ◦C with
TB medium flowing around the bacteria.
Cell Specific Growth
Rate (min−1)
Deviation
(min−1) R
2 (Fit)
Doubling
Time (min)
Deviation
(min)
A.1 0.0125 0.0005 0.9790 56 2
B.1 0.0151 0.0007 0.9694 46 2
B.2 0.0112 0.0004 0.9789 62 2
C.1 0.0111 0.0004 0.9859 63 2
C.2 0.0164 0.0007 0.9773 42 2
Mean 0.0131 0.0003 0.9928 53 1
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3.4. Antibiotic Treatment Experiments
After testing the growth of E. coli in the microchip in a capsuled environment, the influence of
an antibiotic with an inhibitory effect on the bacteria was used to evaluate if the proliferation could
be hindered in a short time. Therefore, a growth experiment with 200 µg/mL kanamycin added to
the TB medium was carried out. The capture was done with 106 cells/mL and at 37◦ C as previously
performed. After 3 min of cell capturing, the pressure parameters were switched to growth mode.
Every 30 s, a fluorescent image was taken over a period of 90 min. After the experiments, the fluorescent
images were analyzed and the bacterial chain length was measured. Figure 8 shows the results of
these experiments in direct comparison to the average length of the experiments in the antibiotic-free
medium above. It is recognizable that the kanamycin is hindering the E. coli to proliferate as the
length is not enlarging over time, whereas the bacteria in the kanamycin free-medium start growing
directly from the beginning with a mean growth rate of 0.0131 min−1 and a doubling time of 53 min,
respectively (Table 2). The results show that a difference in growth behavior can be seen already 15 min
after finishing the loading procedure. This makes this BCF principle capable of holding bacteria back
in a desired area while supplying antibiotics or other drugs to the captured bacteria in short time.
Micromachines 2019, 10, x 10 of 12 
 
capable of holding bacteria back in a desired area while supplying antibiotics or other drugs to the 
captured bacteria in short time. 
  
(a) (b) 
Figure 8. (a) Mean length growth, (b) mean logarithmic length growth with and without 200 µg/mL 
kanamycin in TB medium at 37 °C at the nanogap. Statistical significance was tested using two-sample 
t-test with a significance level of 0.01. Calculated p-values (<0.01) indicate that the growth rate of the 
antibiotic treated bacteria (n = 4) differs significantly from the population without treatment (n = 5). 
4. Conclusions 
In this study, we demonstrated a novel nanogap capturing principle, which enables the 
immobilization of vivid E. coli cells for their later use in lab-on-a-chip optical-detection devices. In 
simulations and experiments we showed that this capture method does not damage the bacteria and 
allows proliferation. By using bypass channels, antibiotics or other drugs can be transported into the 
capture channels within seconds. Thus, the influence on the bacterial proliferation of these drugs can 
be investigated. Instead of image analysis requiring fluorescence microscopy (and fluorescent 
microorganisms), this capturing principle could be achieved within many channels in parallel to 
measure refractive index change due to bacterial growth by the diffraction of a laser beam that 
irradiates the grating. This diffractive approach has so far only been used for the label-free detection 
of proteins [35] and will be investigated in our future research for fast antibiotic susceptibility testing 
(AST). In addition, such a principle can be applied in phase-contrast investigations in which bacteria 
are to be immobilized without markers. It could thus prove also as a helpful tool in persistence 
research where single-cell growth behavior is observed. 
Author Contributions: Conceptualization, J.B. and A.D.; investigation, J.B. and S.M.; data curation, J.B. and S.M.; 
validation, J.B. and A.D.; writing—original draft preparation, J.B.; writing—review and editing, J.B., A.D., and 
S.M.; visualization, J.B. and S.M.; resources, M.S.; supervision, A.D. 
Funding: This research was funded by the Federal Ministry of Education and Research (BMBF), Germany, grant 
number 13N13838. 
Conflicts of Interest: The authors declare no conflict of interest. 
References 
1. Avesar, J.; Rosenfeld, D.; Truman-Rosentsvit, M.; Ben-Arye, T.; Geffen, Y.; Bercovici, M.; 
Levenberg, S. Rapid phenotypic antimicrobial susceptibility testing using nanoliter arrays. Proc. 
Natl. Acad. Sci. 2017, 114, E5787–E5795. 
2. O’Neill, J. Tackling drug-resistant infections globally: Final report and recommendations. Rev. 
Antimicrob. Res. 2017, 2017, 171–174. 
3. Llor, C.; Bjerrum, L. Antimicrobial resistance: Risk associated with antibiotic overuse and 
initiatives to reduce the problem. Ther. Adv. Drug Saf. 2014, 5, 229–241. 
Figure 8. (a) Mean length growth, (b) mean logarithmic length growth with and without 200 µg/mL
kanamycin in TB medium at 37 ◦C at the nanogap. Statistical significance was tested using two-sample
t-test with a significance level of 0.01. Calculated p-values (<0.01) indicate that the growth rate of the
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4. Conclusions
In this study, we demonstrated a novel nanogap capturing principle, which enables the
immobilization of vivid E. coli cells for their later use in lab-on-a-chip optical-detection devices.
In simulations and experiments we showed that this capture method does not damage the bacteria
and allows proliferation. By using bypass channels, antibiotics or other drugs can be transported into
the capture channels within seconds. Thus, the influence on the bacterial proliferation of these drugs
can be investigated. Instead of image analysis requiring fluorescence microscopy (and fluorescent
microorganisms), this capturing principle could be achieved within many channels in parallel to
measure refractive index change due to bacterial growth by the diffraction of a laser beam that
irradiates the grating. This diffractive approach has so far only been used for the label-free detection of
proteins [35] and will be investigated in our future research for fast antibiotic susceptibility testing
(AST). In addition, such a principle can be applied in phase-contrast investigations in which bacteria
are to be immobilized without markers. It could thus prove also as a helpful tool in persistence research
where single-cell growth behavior is observed.
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Funding: This research was funded by the Federal Ministry of Education and Research (BMBF), Germany, grant
number 13N13838.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Avesar, J.; Rosenfeld, D.; Truman-Rosentsvit, M.; Ben-Arye, T.; Geffen, Y.; Bercovici, M.; Levenberg, S. Rapid
phenotypic antimicrobial susceptibility testing using nanoliter arrays. Proc. Natl. Acad. Sci. USA 2017,
114, E5787–E5795. [CrossRef] [PubMed]
2. O’Neill, J. Tackling drug-resistant infections globally: Final report and recommendations. Rev. Antimicrob. Res.
2017, 2017, 171–174.
3. Llor, C.; Bjerrum, L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to
reduce the problem. Ther. Adv. Drug Saf. 2014, 5, 229–241. [CrossRef] [PubMed]
4. Jorgensen, J.H.; Ferraro, M.J. Antimicrobial susceptibility testing: A review of general principles and
contemporary practices. Clin. Infect. Dis. 2009, 49, 1749–1755. [CrossRef] [PubMed]
5. Stamper, P.D.; Louie, L.; Wong, H.; Simor, A.E.; Farley, J.E.; Carroll, K.C. Genotypic and
phenotypic characterization of methicillin-susceptible Staphylococcus aureus isolates misidentified as
methicillin-resistant Staphylococcus aureus by the BD GeneOhm MRSA assay. J. Clin. Microbiol. 2011,
49, 1240–1244. [CrossRef]
6. Garcia-Prats, J.A.; Cooper, T.R.; Schneider, V.F.; Stager, C.E.; Hansen, T.N. Rapid detection of microorganisms
in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000, 105, 523–527.
[CrossRef]
7. Mishra, P.; Mishra, K.P.; Singh, D.; Ganju, L.; Kumar, B.; Singh, S.B. Advances in Rapid Detection and
Antimicrobial Susceptibility Tests: A Review. Def. Life Sc. J. 2019, 4, 12–20. [CrossRef]
8. Choi, J.; Jung, Y.-G.; Kim, J.; Kim, S.; Jung, Y.; Na, H.; Kwon, S. Rapid antibiotic susceptibility testing by
tracking single cell growth in a microfluidic agarose channel system. Lab Chip 2013, 13, 280–287. [CrossRef]
9. Hou, Z.; An, Y.; Hjort, K.; Hjort, K.; Sandegren, L.; Wu, Z. Time lapse investigation of antibiotic susceptibility
using a microfluidic linear gradient 3D culture device. Lab Chip 2014, 14, 3409–3418. [CrossRef]
10. Li, B.; Qiu, Y.; Glidle, A.; McIlvenna, D.; Luo, Q.; Cooper, J.; Shi, H.-C.; Yin, H. Gradient microfluidics enables
rapid bacterial growth inhibition testing. Anal. Chem. 2014, 86, 3131–3137. [CrossRef]
11. Wang, P.; Robert, L.; Pelletier, J.; Dang, W.L.; Taddei, F.; Wright, A.; Jun, S. Robust growth of Escherichia coli.
Curr. Biol. 2010, 20, 1099–1103. [CrossRef] [PubMed]
Micromachines 2019, 10, 691 11 of 12
12. Baltekin, O.; Boucharin, A.; Tano, E.; Andersson, D.I.; Elf, J. Fast antibiotic susceptibility testing based on
single cell growth rate measurements. BioRxiv 2017, 201, 071407.
13. Baltekin, Ö.; Boucharin, A.; Tano, E.; Andersson, D.I.; Elf, J. Antibiotic susceptibility testing in less than 30 min
using direct single-cell imaging. Proc. Natl. Acad. Sci. USA 2017, 114, 9170–9175. [CrossRef] [PubMed]
14. Churski, K.; Kaminski, T.S.; Jakiela, S.; Kamysz, W.; Baranska-Rybak, W.; Weibel, D.B.; Garstecki, P. Rapid
screening of antibiotic toxicity in an automated microdroplet system. Lab Chip 2012, 12, 1629–1637. [CrossRef]
15. Baraban, L.; Bertholle, F.; Salverda, M.L.M.; Bremond, N.; Panizza, P.; Baudry, J.; de Visser, J.A.G.M.; Bibette, J.
Millifluidic droplet analyser for microbiology. Lab Chip 2011, 11, 4057–4062. [CrossRef]
16. Kaminski, T.S.; Scheler, O.; Garstecki, P. Droplet microfluidics for microbiology: Techniques, applications
and challenges. Lab Chip 2016, 16, 2168–2187. [CrossRef]
17. Shang, L.; Cheng, Y.; Zhao, Y. Emerging droplet microfluidics. Chem. Rev. 2017, 117, 7964–8040. [CrossRef]
18. Liu, X.; Painter, R.E.; Enesa, K.; Holmes, D.; Whyte, G.; Garlisi, C.G.; Monsma, F.J.; Rehak, M.; Craig, F.F.;
Smith, C.A. High-throughput screening of antibiotic-resistant bacteria in picodroplets. Lab Chip 2016,
16, 1636–1643. [CrossRef]
19. Hesselman, M.C.; Odoni, D.I.; Ryback, B.M.; de Groot, S.; van Heck, R.G.A.; Keijsers, J.; Kolkman, P.;
Nieuwenhuijse, D.; van Nuland, Y.M.; Sebus, E.; et al. A multi-platform flow device for microbial (co-)
cultivation and microscopic analysis. PLoS ONE 2012, 7, e36982. [CrossRef]
20. Besant, J.D.; Sargent, E.H.; Kelley, S.O. Rapid electrochemical phenotypic profiling of antibiotic-resistant
bacteria. Lab Chip 2015, 15, 2799–2807. [CrossRef]
21. Mohan, R.; Mukherjee, A.; Sevgen, S.E.; Sanpitakseree, C.; Lee, J.; Schroeder, C.M.; Kenis, P.J.A. A multiplexed
microfluidic platform for rapid antibiotic susceptibility testing. Biosens. Bioelectron. 2013, 49, 118–125.
[CrossRef] [PubMed]
22. Pitruzzello, G.; Thorpe, S.; Johnson, S.; Evans, A.; Gadêlha, H.; Krauss, T.F. Multiparameter antibiotic
resistance detection based on hydrodynamic trapping of individual E. coli. Lab Chip 2019, 19, 1417–1426.
[CrossRef] [PubMed]
23. Kara, V.; Duan, C.; Gupta, K.; Kurosawa, S.; Stearns-Kurosawa, D.J.; Ekinci, K.L. Microfluidic detection of
movements of Escherichia coli for rapid antibiotic susceptibility testing. Lab Chip 2018, 18, 743–753. [CrossRef]
[PubMed]
24. Tang, M.; Huang, X.; Chu, Q.; Ning, X.; Wang, Y.; Kong, S.-K.; Zhang, X.; Wang, G.; Ho, H.-P. A linear
concentration gradient generator based on multi-layered centrifugal microfluidics and its application in
antimicrobial susceptibility testing. Lab Chip 2018, 18, 1452–1460. [CrossRef]
25. Kim, K.P.; Kim, Y.-G.; Choi, C.-H.; Kim, H.-E.; Lee, S.-H.; Chang, W.-S.; Lee, C.-S. In situ monitoring of
antibiotic susceptibility of bacterial biofilms in a microfluidic device. Lab Chip 2010, 10, 3296–3299. [CrossRef]
26. Shirure, V.S.; George, S.C. Design considerations to minimize the impact of drug absorption in polymer-based
organ-on-a-chip platforms. Lab Chip 2017, 17, 681–690. [CrossRef]
27. Toepke, M.W.; Beebe, D.J. PDMS absorption of small molecules and consequences in microfluidic applications.
Lab Chip 2006, 6, 1484–1486. [CrossRef]
28. Van Meer, B.J.; de Vries, H.; Firth, K.S.A.; van Weerd, J.; Tertoolen, L.G.J.; Karperien, H.B.J.; Jonkheijm, P.;
Denning, C.; IJzerman, A.P.; Mummery, C.L. Small molecule absorption by PDMS in the context of drug
response bioassays. Biochem. Biophys. Res. Commun. 2017, 482, 323–328. [CrossRef]
29. Yang, M.; Li, C.-W.; Yang, J. Cell docking and on-chip monitoring of cellular reactions with a controlled
concentration gradient on a microfluidic device. Anal. Chem. 2002, 74, 3991–4001. [CrossRef]
30. Bates, R.L.; Stephan Thamban, P.L.; Goeckner, M.J.; Overzet, L.J. Silicon etch using SF6/C4F8/Ar gas mixtures.
J. Vac. Technol. 2014, 32, 041302. [CrossRef]
31. Hoang, T.T.; Karkhoff-Schweizer, R.R.; Kutchma, A.J.; Schweizer, H.P. A broad-host-range Flp-FRT
recombination system for site-specific excision of chromosomally-located DNA sequences: Application for
isolation of unmarked Pseudomonas aeruginosa mutants. Gene 1998, 212, 77–86. [CrossRef]
32. Bongaerts, G.P.; Kaptijn, G.M. Aminoglycoside phosphotransferase-II-mediated amikacin resistance in
Escherichia coli. Antimicrob. Agents Chemother. 1981, 20, 344–350. [CrossRef] [PubMed]
33. Lange, H.; Taillandier, P.; Riba, J.-P. Effect of high shear stress on microbial viability. J. Chem. Technol. Biotechnol.
2001, 76, 501–505. [CrossRef]
Micromachines 2019, 10, 691 12 of 12
34. Dhar, N.; McKinney, J.D. Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol.
2007, 10, 30–38. [CrossRef] [PubMed]
35. Purr, F.; Bassu, M.; Lowe, R.D.; Thürmann, B.; Dietzel, A.; Burg, T.P. Asymmetric nanofluidic grating detector
for differential refractive index measurement and biosensing. Lab Chip 2017, 17, 4265–4272. [CrossRef]
[PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
